3D-Lab: a collaborative web-based platform for molecular modeling.

AIM The use of 3D information has shown impact in numerous applications in drug design. However, it is often under-utilized and traditionally limited to specialists. We want to change that, and present an approach making 3D information and molecular modeling accessible and easy-to-use 'for the people'. METHODOLOGY/RESULTS A user-friendly and collaborative web-based platform (3D-Lab) for 3D modeling, including a blazingly fast virtual screening capability, was developed. 3D-Lab provides an interface to automatic molecular modeling, like conformer generation, ligand alignments, molecular dockings and simple quantum chemistry protocols. 3D-Lab is designed to be modular, and to facilitate sharing of 3D-information to promote interactions between drug designers. Recent enhancements to our open-source virtual reality tool Molecular Rift are described. CONCLUSION The integrated drug-design platform allows drug designers to instantaneously access 3D information and readily apply advanced and automated 3D molecular modeling tasks, with the aim to improve decision-making in drug design projects.

[1]  Jonas Boström,et al.  Assessing the performance of OMEGA with respect to retrieving bioactive conformations. , 2003, Journal of molecular graphics & modelling.

[2]  Michael J. Hartshorn,et al.  AstexViewerTM †: a visualisation aid for structure-based drug design , 2002, J. Comput. Aided Mol. Des..

[3]  Jonas Boström,et al.  Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? , 2016, Journal of medicinal chemistry.

[4]  Jonas Boström,et al.  Exploiting Ligand Conformations in Drug Design , 2007 .

[5]  A. Anderson.  The process of structure-based drug design. , 2003, Chemistry & biology.

[6]  Peter W. Kenny,et al.  Prediction of hydrogen bond basicity from computed molecular electrostatic properties: implications for comparative molecular field analysis , 1994 .

[7]  J. Ladbury.  Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. , 1996, Chemistry & biology.

[8]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[9]  Robert P. Sheridan,et al.  Comparison of Topological, Shape, and Docking Methods in Virtual Screening , 2007, J. Chem. Inf. Model..

[10]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[11]  Jonas Boström,et al.  Molecular Rift: Virtual Reality for Drug Designers , 2015, J. Chem. Inf. Model..

[12]  Peter Gedeck,et al.  FOCUS - Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists , 2015, J. Chem. Inf. Model..

[13]  Kwong-Sak Leung,et al.  iview: an interactive WebGL visualizer for protein-ligand complex , 2014, BMC Bioinformatics.

[14]  F. Riddell,et al.  J. H. van't Hoff and J. A. Le Bel—their historical context , 1974 .

[15]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[16]  Mark McGann,et al.  FRED Pose Prediction and Virtual Screening Accuracy , 2011, J. Chem. Inf. Model..

[17]  F. Allen.  The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.